高级检索
郑本锋, 刘宏伟, 袁源, 刘春华, 王哲, 杨利婷, 邢辉, 阮玉华, 邵一鸣. HIV抗病毒治疗者病毒抑制失败影响因素及耐药[J]. 中国公共卫生, 2011, 27(6): 728-730. DOI: 10.11847/zgggws2011-27-06-23
引用本文: 郑本锋, 刘宏伟, 袁源, 刘春华, 王哲, 杨利婷, 邢辉, 阮玉华, 邵一鸣. HIV抗病毒治疗者病毒抑制失败影响因素及耐药[J]. 中国公共卫生, 2011, 27(6): 728-730. DOI: 10.11847/zgggws2011-27-06-23
ZHENG Ben-feng, LIU Hong-wei, YUAN Yuan, . Virological suppression failure and drug resistance in HIV-infected patients receiving antiretroviral therapy in Xihua county, Henan province[J]. Chinese Journal of Public Health, 2011, 27(6): 728-730. DOI: 10.11847/zgggws2011-27-06-23
Citation: ZHENG Ben-feng, LIU Hong-wei, YUAN Yuan, . Virological suppression failure and drug resistance in HIV-infected patients receiving antiretroviral therapy in Xihua county, Henan province[J]. Chinese Journal of Public Health, 2011, 27(6): 728-730. DOI: 10.11847/zgggws2011-27-06-23

HIV抗病毒治疗者病毒抑制失败影响因素及耐药

Virological suppression failure and drug resistance in HIV-infected patients receiving antiretroviral therapy in Xihua county, Henan province

  • 摘要: 目的 了解抗病毒治疗者病毒抑制失败影响因素和耐药状况.方法 2009年8月在河南省西华县整群抽取接受抗病毒治疗者371例,进行基本情况和抗病毒治疗相关因素问卷调查,同时抽取静脉血进行病毒载量检测,对病毒载量>1 000拷贝/mL的血液样本采用逆转录-套式聚合酶链反应(RT-nested PCR)方法扩增HIV-1 POL区基因,进行耐药基因型分析.结果 371例中,病毒抑制失败87例,失败率为23.5%;多因素Logistic回归分析结果显示,男性(OR=1.8,95%CI=1.1~3.1,P=0.026 4)、最近1个月有漏服药物(OR=2.3,95%CI=1.2~4.2,P=0.009 2)和现治疗方案为早期一线治疗方案(OR=2.1,95%CI=1.2~3.9,P=0.012 4)与病毒抑制失败率的关系有统计学意义;病毒抑制失败者的耐药率为63.2%(55/87),其中非核苷类药物和核苷类药物的耐药率分别为63.2%(55/87)和49.3%(43/87),未检测到对蛋白酶类药物的耐药.结论 抗病毒治疗人群中病毒抑制失败率和耐药突变率较高,服药依从性是主要影响因素.

     

    Abstract: Objective To study virological suppression failure and drug resistance among HIV-infected patients receiving antiretroviral therapy in Xihua county,Henan province.Methods In August 2009,participants with HIV-infection and receiving antivretroviral therapy(ART) were investigated to collect information on socio-demographics and treatments in Xihua county.Blood samples were collected for viral load test and genotypic resistance was determined in those with a viral load of > 1 000 copies/ml,and the HIV pol was amplified and sequenced using RT-nested PCR.Results Overall,23.5% of the participants demonstrating virological failure.In a multiple logistic regression model,male(odds ratioOR=1.8,95% confidence intervalCI:1.1-3.1; P=0.0264),failing to adherence in the last month(OR=2.3,95% CI:1.2-4.2; P=0.0092),with a didanosine-based regimen currently prescribed(OR=2.3,95% CI:1.2-4.2; P=0.012 4) were significantly associated with virological failure(viral load > 1 000 copies/ml).Of the participants demonstrating virological failure,63.2%(55/87) experienced drug resistance,63.2%(55/87) and 49.3%(43/87) experienced drug resistance to nonnucleoside reverse-transcriptase inhibitor(NNRTI) and nucleoside reverse-transcriptase inhibitor(NRTI),respectively.There was no protease inhibitor resistance observed.Conclusion The rates of virological failure and drug resistance in patients receiving ART are high.Intervention measures should be taken to enhance adherence in order to improve outcomes of antiretroviral therapy.

     

/

返回文章
返回